Shadab Ataur Rahman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melatonin | 25 | 2023 | 670 | 6.950 |
Why?
|
| Circadian Rhythm | 32 | 2023 | 2593 | 4.870 |
Why?
|
| Lighting | 8 | 2023 | 210 | 3.120 |
Why?
|
| Light | 14 | 2022 | 1355 | 3.120 |
Why?
|
| Wakefulness | 10 | 2023 | 1284 | 2.380 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 7 | 2022 | 197 | 2.230 |
Why?
|
| Sleep | 25 | 2023 | 4819 | 1.570 |
Why?
|
| Work Schedule Tolerance | 9 | 2023 | 553 | 1.200 |
Why?
|
| Progesterone | 3 | 2022 | 752 | 1.030 |
Why?
|
| Sleep Deprivation | 7 | 2024 | 848 | 1.010 |
Why?
|
| Estradiol | 6 | 2024 | 1951 | 0.920 |
Why?
|
| Follicular Phase | 2 | 2020 | 143 | 0.820 |
Why?
|
| Luminescent Agents | 1 | 2022 | 29 | 0.810 |
Why?
|
| Phototherapy | 2 | 2014 | 368 | 0.710 |
Why?
|
| Medical Errors | 4 | 2021 | 1260 | 0.690 |
Why?
|
| Circadian Clocks | 3 | 2020 | 168 | 0.680 |
Why?
|
| Attention | 7 | 2024 | 2424 | 0.670 |
Why?
|
| Psychomotor Performance | 5 | 2024 | 1892 | 0.670 |
Why?
|
| Personnel Staffing and Scheduling | 5 | 2023 | 497 | 0.660 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2022 | 727 | 0.610 |
Why?
|
| Uterine Contraction | 1 | 2019 | 91 | 0.610 |
Why?
|
| Photic Stimulation | 2 | 2021 | 1997 | 0.560 |
Why?
|
| Luteinizing Hormone | 1 | 2019 | 822 | 0.560 |
Why?
|
| Hydrocortisone | 3 | 2023 | 1841 | 0.560 |
Why?
|
| Lipids | 3 | 2023 | 3343 | 0.520 |
Why?
|
| Task Performance and Analysis | 2 | 2021 | 771 | 0.460 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1107 | 0.400 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 605 | 0.390 |
Why?
|
| Interleukin-8 | 1 | 2014 | 704 | 0.380 |
Why?
|
| Young Adult | 20 | 2024 | 60066 | 0.370 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2014 | 892 | 0.370 |
Why?
|
| Endocrine Glands | 1 | 2010 | 101 | 0.360 |
Why?
|
| Internship and Residency | 5 | 2023 | 5953 | 0.350 |
Why?
|
| Time Factors | 13 | 2022 | 40218 | 0.330 |
Why?
|
| Central Nervous System Depressants | 1 | 2009 | 163 | 0.320 |
Why?
|
| Adaptation, Physiological | 3 | 2022 | 1312 | 0.300 |
Why?
|
| Behavior | 1 | 2010 | 542 | 0.290 |
Why?
|
| Endocrine System | 1 | 2008 | 113 | 0.290 |
Why?
|
| Adult | 29 | 2024 | 223646 | 0.290 |
Why?
|
| Premenopause | 2 | 2024 | 1039 | 0.280 |
Why?
|
| Cognition | 3 | 2023 | 7073 | 0.270 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 2219 | 0.270 |
Why?
|
| Female | 33 | 2024 | 397192 | 0.270 |
Why?
|
| Occupational Health | 1 | 2013 | 812 | 0.270 |
Why?
|
| Darkness | 2 | 2018 | 160 | 0.260 |
Why?
|
| Polysomnography | 4 | 2017 | 1871 | 0.250 |
Why?
|
| Humans | 49 | 2024 | 768166 | 0.240 |
Why?
|
| Patient Compliance | 1 | 2015 | 2697 | 0.240 |
Why?
|
| Workload | 2 | 2021 | 849 | 0.230 |
Why?
|
| Saliva | 4 | 2023 | 853 | 0.230 |
Why?
|
| Cross-Over Studies | 5 | 2020 | 2107 | 0.220 |
Why?
|
| Nurses | 1 | 2013 | 2501 | 0.220 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2021 | 1027 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 4352 | 0.210 |
Why?
|
| Photoperiod | 2 | 2014 | 141 | 0.210 |
Why?
|
| Globulins | 1 | 2022 | 19 | 0.200 |
Why?
|
| Male | 25 | 2022 | 364719 | 0.200 |
Why?
|
| Perimenopause | 1 | 2022 | 142 | 0.190 |
Why?
|
| Azepines | 1 | 2022 | 329 | 0.170 |
Why?
|
| Depression | 2 | 2009 | 8230 | 0.170 |
Why?
|
| Sleep Stages | 2 | 2014 | 706 | 0.170 |
Why?
|
| Luteal Phase | 1 | 2020 | 138 | 0.160 |
Why?
|
| Receptors, Melatonin | 1 | 2019 | 31 | 0.160 |
Why?
|
| Albumins | 1 | 2022 | 577 | 0.160 |
Why?
|
| Reaction Time | 3 | 2024 | 2101 | 0.160 |
Why?
|
| Postprandial Period | 1 | 2021 | 320 | 0.160 |
Why?
|
| Time | 1 | 2020 | 552 | 0.150 |
Why?
|
| Long-Term Care | 1 | 2022 | 631 | 0.150 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2019 | 553 | 0.140 |
Why?
|
| Actigraphy | 1 | 2021 | 527 | 0.140 |
Why?
|
| Triazoles | 1 | 2022 | 904 | 0.130 |
Why?
|
| Body Temperature | 1 | 2019 | 780 | 0.130 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 587 | 0.130 |
Why?
|
| Rest | 1 | 2019 | 948 | 0.120 |
Why?
|
| Bone Resorption | 1 | 2018 | 728 | 0.110 |
Why?
|
| Perception | 1 | 2020 | 1209 | 0.110 |
Why?
|
| Temperature | 1 | 2020 | 2234 | 0.110 |
Why?
|
| Employee Performance Appraisal | 1 | 2013 | 86 | 0.100 |
Why?
|
| Double-Blind Method | 2 | 2022 | 12465 | 0.100 |
Why?
|
| Self Report | 2 | 2022 | 3773 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4580 | 0.100 |
Why?
|
| Ontario | 1 | 2013 | 403 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1798 | 0.100 |
Why?
|
| Proteome | 1 | 2022 | 1890 | 0.100 |
Why?
|
| Eyelids | 1 | 2013 | 278 | 0.090 |
Why?
|
| Electroencephalography | 3 | 2017 | 6314 | 0.090 |
Why?
|
| Models, Theoretical | 2 | 2022 | 3573 | 0.090 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2010 | 31 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2023 | 3445 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2023 | 8741 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2009 | 6029 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2021 | 3205 | 0.080 |
Why?
|
| Adolescent | 6 | 2020 | 89169 | 0.080 |
Why?
|
| CLOCK Proteins | 1 | 2008 | 87 | 0.070 |
Why?
|
| Massachusetts | 1 | 2021 | 8890 | 0.070 |
Why?
|
| Corticosterone | 1 | 2008 | 301 | 0.070 |
Why?
|
| Photons | 1 | 2010 | 594 | 0.070 |
Why?
|
| Gene Expression | 2 | 2010 | 7598 | 0.070 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2008 | 619 | 0.070 |
Why?
|
| Heart Rate | 1 | 2018 | 4214 | 0.070 |
Why?
|
| Liver | 1 | 2022 | 7577 | 0.060 |
Why?
|
| Physicians | 1 | 2023 | 4598 | 0.060 |
Why?
|
| Affect | 1 | 2013 | 1495 | 0.060 |
Why?
|
| Middle Aged | 6 | 2024 | 223492 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6229 | 0.060 |
Why?
|
| Aging | 1 | 2023 | 8744 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2862 | 0.060 |
Why?
|
| Homeostasis | 1 | 2014 | 3348 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3814 | 0.050 |
Why?
|
| Rod Opsins | 1 | 2022 | 108 | 0.050 |
Why?
|
| Calorimetry, Indirect | 1 | 2022 | 176 | 0.050 |
Why?
|
| Jet Lag Syndrome | 1 | 2021 | 24 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2022 | 65371 | 0.050 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2022 | 183 | 0.050 |
Why?
|
| Psychometrics | 1 | 2010 | 3063 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2008 | 5027 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2022 | 389 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2023 | 555 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 59629 | 0.040 |
Why?
|
| Gerbillinae | 1 | 2019 | 87 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2023 | 702 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2008 | 2167 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2008 | 2857 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 7140 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 8128 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2023 | 81762 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 30256 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2022 | 811 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2022 | 2227 | 0.030 |
Why?
|
| Cricetinae | 1 | 2019 | 2423 | 0.030 |
Why?
|
| Menopause | 1 | 2023 | 1656 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 1820 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2018 | 618 | 0.030 |
Why?
|
| Eye Movement Measurements | 1 | 2013 | 32 | 0.030 |
Why?
|
| Triglycerides | 1 | 2022 | 2464 | 0.030 |
Why?
|
| Animals | 4 | 2019 | 169246 | 0.030 |
Why?
|
| Blinking | 1 | 2013 | 135 | 0.030 |
Why?
|
| Cholesterol | 1 | 2022 | 2914 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 2403 | 0.020 |
Why?
|
| Aged | 2 | 2022 | 171504 | 0.020 |
Why?
|
| Rats | 1 | 2008 | 23760 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 15454 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 17140 | 0.020 |
Why?
|
| Health Services Research | 1 | 2019 | 1815 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2022 | 2907 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2022 | 3329 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 20227 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 27360 | 0.020 |
Why?
|
| Motor Activity | 1 | 2019 | 2711 | 0.020 |
Why?
|
| Hospitals | 1 | 2020 | 3886 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3800 | 0.020 |
Why?
|
| Peptides | 1 | 2018 | 4354 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 41754 | 0.020 |
Why?
|
| Risk Factors | 1 | 2008 | 74944 | 0.010 |
Why?
|
| Algorithms | 1 | 2022 | 14164 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 22371 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 54926 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 82029 | 0.010 |
Why?
|